Literature DB >> 8780008

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons.

Y Goodman1, A J Bruce, B Cheng, M P Mattson.   

Abstract

Steroid hormones, particularly estrogens and glucocorticoids, may play roles in the pathogenesis of neurodegenerative disorders, but their mechanisms of action are not known. We report that estrogens protect cultured hippocampal neurons against glutamate toxicity, glucose deprivation, FeSO4 toxicity, and amyloid beta-peptide (A beta) toxicity. The toxicity of each insult was significantly attenuated in cultures pretreated for 2 h with 100 nM-10 microM 17 beta-estradiol, estriol, or progesterone. In contrast, corticosterone exacerbated neuronal injury induced by glutamate, FeSO4, and A beta. Several other steroids, including testosterone, aldosterone, and vitamin D, had no effect on neuronal vulnerability to the different insults. The protective actions of estrogens and progesterone were not blocked by actinomycin D or cycloheximide. Lipid peroxidation induced by FeSO4 and A beta was significantly attenuated in neurons and isolated membranes pretreated with estrogens and progesterone, suggesting that these steroids possess antioxidant activities. Estrogens and progesterone also attenuated A beta- and glutamate-induced elevation of intracellular free Ca2+ concentrations. We conclude that estrogens, progesterone, and corticosterone can directly affect neuronal vulnerability to excitotoxic, metabolic, and oxidative insults, suggesting roles for these steroids in several different neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780008     DOI: 10.1046/j.1471-4159.1996.66051836.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  165 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

3.  The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons.

Authors:  C A Singer; X A Figueroa-Masot; R H Batchelor; D M Dorsa
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 4.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 5.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

6.  Progesterone enhances transthyretin expression in the rat choroid plexus in vitro and in vivo via progesterone receptor.

Authors:  Telma Quintela; Isabel Gonçalves; Ana Martinho; Celso Henrique Alves; Maria João Saraiva; Pedro Rocha; Cecília Reis Alves Santos
Journal:  J Mol Neurosci       Date:  2010-06-10       Impact factor: 3.444

Review 7.  Hormonal influences on cognition and risk for Alzheimer's disease.

Authors:  Sarah C Janicki; Nicole Schupf
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

8.  Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity.

Authors:  E Gursoy; A Cardounel; M Kalimi
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 9.  Progesterone, brain-derived neurotrophic factor and neuroprotection.

Authors:  M Singh; C Su
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 10.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.